Kalvista Pharmaceuticals Limited

Kalvista Pharmceuticals Limited

Stephen John Pethen

David Michael Evans

Rebecca Louise Davie

Hannah Joy Edwards

Andrzej Roman Batt

Christine Elizabeth Allan

Simon Teanby Hodgson

David Philip Rooker

Hanna Joy Edwards

The present invention provides a selection of compounds of formula (I): (I) compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R5, R6, R7, A, B, W, X, Y and Z are as defined herein. 

Pyrazole derivatives as plasma kallikrein inhibitors

The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R1 to R3, R5 to R9, A, P, V, W, X, Y and Z are as defined herein.

Benzylamine derivatives

The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R1 to R3, R5 to R9, A, P, V, W, X, Y and Z are as defined herein. 

Growing community of inventors

Salisbury, United Kingdom

Stephen John Pethen